Dr. Antonio Grande Trillo

Cardiología. Hospital Universitario Virgen del Rocío. Sevilla.

Biografía

EXPERIENCIA LABORAL
2012-2017: Hospital Universitario Virgen del Rocío. Formación Sanitaria Especializada en Cardiología.
2017 – actualidad: Hospital Universitario Virgen del Rocío. FEA Cardiología. Ud de Insuficiencia Cardíaca Avanzada y Trasplante Cardíaco.

FORMACIÓN
Doctorado por la Universidad de Sevilla en el programa de Biología Molecular y Biomedicina con calificación Cum Laude – 2023.
Certificación como experto en Insuficiencia Cardíaca por la Heart Failure Association by European Society of Cardiology - 2018.
Master en Ecocardiografía Transesofágica por la Universidad de Vitoria - 2018.
Master official en Investigación en Medicina Clínica por la Universidad Miguel Hernández – 2014.
Formación Sanitaria Especializada en Cardiología con premio a residente excelente por Hospital Universitario Virgen del Rocío - 2017.
Grado en Medicina por la Universidad Autónoma de Barcelona - 2011.

PUBLICACIONES MÁS RELEVANTES
- Jose Gonzalez Costello; Antonio Grande Trillo; Carmen Baliellas; et al. Transthyretin amyloidosis with cardiomyopathy after domino liver transplantation: Results of a cross-sectional study. American Journal of Transplantation 2020; 237
- González-Quijano M, Grande-Trillo A, Esteve-Ruiz I, et al. Elevated Lipoprotein A Levels and Development of Moderate or Severe Cardiac Allograft Vasculopathy in Patients with Heart Transplants. Transplant Proc. 2023; 30.
- Eva M Cantero; Ines Sayago; Jose Manuel Sobrino; Diego Rangel-Sousa; Antonio Grande-Trillo; Kambiz Rezaei; Alejdandro Adsuar. Impact of Preoperative Pulmonary Hypertension on Survival in Patients Undergoing Elective Heart Transplant. Transplantation Proceedings 2020;52 (2).
- Monteagudo Ruiz, Juan Manuel; Galderisi, Maurizio; et al. Overview of mitral regurgitation in Europe: results from the European Registry of mitral regurgitation (EuMiClip). European Heart Journal – Cardiovascular Imaging 2018; 19.
- Sobrino-Márquez, J. M.; Grande-Trillo, A.; Cantero-Perez, et al. Prognostic Value of Blood Panel Parameters in Patients With Dilated Cardiomyopathy and Advanced Heart Failure. Transplantation proceedings 2018; 50.
- Esteve-Ruiz, I.; Grande-Trillo, A.; Rangel-Sousa, D.; et al. Complex Congenital Heart Disease: Is Heart Transplantation an Option?. Transplantation proceedings 2018 ; 50.
- Monteagudo Ruiz, Juan Manuel; Fernandez-Golfin, Covadonga; Mesa, Dolores; et al. Prevalence of optimal valve morphology for MitraClip in patients with mitral regurgitation. Echocardiography 2017; 34.
- Antonio Grande Trillo; Iris M Esteve Ruiz; Javier Matabuena Gomez-Limón; Eduardo Arana Rueda. Uso actual y complicaciones del marcapasos transitorio endocavitario urgente en un centro de tercer nivel. Cardiocore 2017; 52 (1): 11-15.
- José L Zamorano; Juan Manuel Monteagudo; et al. Frequency, Mechanism and Severity of Mitral Regurgitation: Are There any Differences Between Primary and Secondary Mitral Regurgitation?. The Journal of Heart Valve Disease 2016; 25 (5).
- Grande-Trillo, A.; Sobrino-Marquez, J. M.; Escobedo-Mesas, E.; et al. Preoperative Cardiac Assessment of Patients Undergoing Orthotopic Liver Transplantation: Experience in One Center. Transplantation proceedings 2015; 47.
- Iris Esteve Ruiz; Antonio Grande Trillo; Domingo Acosta Delgado. Factores de riesgo cardiovascular, ¿realmente existe una relación con el nivel educativo? Cardiocore 2015; 50 (1): 34-37.
- Cantero Pérez, EM; Sobrino Márquez, JM; Grande Trillo, A.; et al. Implantable cardioverter defibrillator for primary prevention in patients with severe ventricular dysfunction awaiting heart transplantation. Transplantation proceedings 2013; 45 (10): 3659-3661.
- Cantero Pérez, EM.; Sobrino Márquez, JM.; Adsuar Gómez, et al. Severe heart failure due to noncompaction cardiomyopathy: a case report. Transplantation proceedings 2013; 45 (10): 3672-3674.

RESEARCH PROJECTS
A randomized, open phase IV Clinical Trial, controlled and multicenter, to evaluate efficacy of preemptive therapy of cytomegalovirus infection in heart transplant recipients based in basal specific lymphocytic T response to cytomegalovirus. ELISPOT-TC. EudraCT: 2019-002233-11. Principal Investigator.
Phase IV Clinical Trial, EVOlocumab in Stable Heart Failure With Reduced Ejection Fraction of Ischemic Etiology: EVO-HF Pilot (EVO-HF). NCT number): NCT03791593.
Stroke prevention and rhythm control Therapy: Evaluation of an Educational Programme of the European society of cardiology in a cluster-Randomized trial in patients with Atrial Fibrillation). EudraCT number: 2020-000792-20, ClinicalTrials.org: NCT04396418.
Donor-derived Cell Free DNA as a New Biomarker in Cardiac Acute Rejection (FreeDNA-CAR). ClinicalTrials.gov Identifier: NCT04973943.
Multidisciplinary and prospective study of novel phenotypic and prognostics indicators in patients with new onset heart failure. Work group REDISCONR III. Foundation National Center of Cardiovascular Research CARLOS III. Principal Investigator.
European Registry of Mitral Regurgitation. Foundation National